ACIST Medical Systems
Based in Eden Prairie, Minnesota, ACIST Medical Systems, part of the Bracco Group, was founded by an interventional cardiologist on a mission.
Dr. Robert (Bob) F. Wilson, Professor of Medicine and Director of the Interventional Cardiology Program at the University of Minnesota, wanted to create a device that took into consideration the needs of both physicians and patients in the cath lab. This sparked the creation of ACIST CVi™, a device that simplifies contrast injection for all procedures.
Since then, ACIST has become a knowledge catalyst, helping interventional cardiologists quickly visualize, assess and improve patient treatment.
The Bracco Group
Bracco is an international Group active in the healthcare sector and a leader in diagnostic imaging. It has around 3,420 employees and annual total consolidated revenues of around 1,29 billion euros, 86% of which from international sales. The Bracco diagnostic imaging product portfolio is completed by medical devices and advanced imaging agents injection systems.
Bracco Injeneering is a company committed to developing the best-in-class integrated injection solutions with a strong heritage in research and innovation. It provides quality solutions for state-of-the-art radiology centers, offering proven injection technology, built on Bracco
Imaging expertise. The product portfolio includes CT Exprès, EmpowerCTA®, EmpowerMR® and Nexo. Bracco Imaging continues to be focused on constant innovation, not only for devices, but also for software development and data management.
Grant Request Form
To submit a grant request to ACIST Medical systems please fill out the Grant Request Form and submit to the ACIST Grants Team at firstname.lastname@example.org. All grant requests must be received 60 days prior to the date of the event or project due date.
Through our relentless commitment to innovation, we optimize interventional decisions, equipping people with the power to get back to life.
Founded by Dr. Robert F. (Bob) Wilson.
Receives FDA clearance to market the CL100H system, the first injection system for diagnostic and interventional cardiology.
Acquired by Milan-based Bracco Group, a world leader in the field of diagnostic imaging.
ACIST CVi Contrast Delivery System launches.
2012ACIST acquires SVMI and the technology for ACIST HDi®.
ACIST RXi® Rapid Exchange FFR System launches.
2014ACIST HDi High-Definition IVUS System launches.
ACIST RXi® Mini™ System launches.
2017Brad Fox is appointed as ACIST President and CEO.
HDi receives peripheral indication.
Products available in more than 60 countries
Employs 400+ people worldwide
Here at ACIST we pride ourselves on being an active member in our local communities by giving back and supporting several nonprofits that help better society. We empower our team to champion efforts to improve the lives of others.
President, Chief Executive Officer
Sr. Vice President, General Manager
Vice President, Quality Assurance
Vice President, Global Operations & Service
Vice President, Human Resources
Vice President, Product Development
Vice President, Research & Technology Integration
Vice President of Sales, Americas
Vice President & General Manager, Diagnostic Devices and Software
Vice President, Finance & IT
Vice President, Regulatory Affairs and Clinical Programs
ACIST Japan President
ACIST Corporate Headquarters
7905 Fuller Road
Eden Prairie, Minnesota 55344
Phone: 952-995-9300 or 888-667-6648
ACIST Silicon Valley
47621 Westinghouse Drive
Fremont, California 94539
ACIST Japan Inc.
7F Dainippon-Tosho Otsuka
3-Chrome Bldg. 3-11-6, Otsuka
Bunkyo-Ku, Tokyo 112-0012
Phone: +81 369029520
See our specialties
ACIST can help with peripheral, cardiovascular disease and structural procedures.